Functional consequences of C-terminal mutations in RUNX2.

Area of Science:

• Genetics
• Molecular Biology
• Developmental Biology

Background:

• Cleidocranial dysplasia (CCD) is a genetic disorder impacting bone and teeth development.
• Mutations in the RUNX2 gene are the primary cause of CCD.
• Previous research primarily focused on RUNX2 RHD domain mutations, with limited exploration of C-terminal domain alterations.

Purpose of the Study:

• To investigate the functional impact of mutations in the C-terminal domain of the RUNX2 gene.
• To analyze how these mutations affect RUNX2 protein activity, localization, and expression.
• To understand the contribution of C-terminal RUNX2 mutations to the pathogenesis of cleidocranial dysplasia.

Main Methods:

• Analysis of eight RUNX2 C-terminal mutations.
• Assessing transactivation activity, protein expression, and subcellular localization of mutant RUNX2 proteins.
• Studying the osteogenic potential of mesenchymal stem cells (MSCs) from CCD patients.

Main Results:

• Truncating mutations in the PST region and a missense mutation in the NMTS region increased RUNX2 transactivation activity.
• Missense mutations in the PST region showed transactivation activity similar to controls.
• Mutant RUNX2 proteins, particularly truncated forms, were mislocalized to the cytoplasm, mirroring observations in CCD patient cells.

Conclusions:

• C-terminal RUNX2 mutations can lead to aberrant protein function, including altered transactivation and mislocalization.
• RUNX2 mislocalization and reduced downstream gene expression in patient-derived cells compromise osteogenic potential.
• This study elucidates the role of RUNX2 C-terminal mutations in cleidocranial dysplasia pathogenesis.